S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motility

British Journal of Cancer

Volumn 101, Issue 7, 2009, Pages 1145-1154

  Nedjadi, T ^a   Kitteringham, N ^a   Campbell, F ^a   Jenkins, R E ^a   Park, B K ^a   Navarro, P ^b   Ashcroft, F ^c   Tepikin, A ^a   Neoptolemos, J P ^a   Costello, E ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Annexin2; Immunoprecipitation; Pancreatic cancer; Proteomics; S100A6

Indexed keywords

CALCYCLIN; LAMIN B; LIPOCORTIN 2; PROTEOME; SMALL INTERFERING RNA; TROPOMYOSIN; TROPOMYOSIN BETA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL MEMBRANE; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MASS SPECTROMETRY; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RNA INTERFERENCE; TWO DIMENSIONAL GEL ELECTROPHORESIS; WOUND HEALING;

ANNEXIN A2; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYTOPLASM; HUMANS; IMMUNOPRECIPITATION; PANCREATIC NEOPLASMS; RNA INTERFERENCE; S100 PROTEINS;

EID: 70349659240     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605289     Document Type: Article

References (49)

1. Aguilar S, Corominas JM, Malats N, Pereira JA, Dufresne M, Real FX, Navarro P (2004) Tissue plasminogen activator in murine exocrine pancreas cancer: selective expression in ductal tumors and contribution to cancer progression. Am J Pathol 165: 1129-1139 (Pubitemid 39297720)
2. Babbin BA, Parkos CA, Mandell KJ, Winfree LM, Laur O, Ivanov AI, Nusrat A (2007) Annexin 2 regulates intestinal epithelial cell spreading and wound closure through Rho-related signaling. Am J Pathol 170: 951-966 (Pubitemid 47339364)
3. Boyd J, Risinger JI, Wiseman RW, Merrick BA, Selkirk JK, Barrett JC (1995) Regulation of microfilament organization and anchorage-independent growth by tropomyosin 1. Proc Natl Acad Sci USA 92: 11534-11538 (Pubitemid 26014148)
4. Breen EC, Tang K (2003) Calcyclin (S100A6) regulates pulmonary fibroblast proliferation, morphology, and cytoskeletal organization in vitro. J Cell Biochem 88: 848-854
5. Brown LM, Helmke SM, Hunsucker SW, Netea-Maier RT, Chiang SA, Heinz DE, Shroyer KR, Duncan MW, Haugen BR (2006) Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue. Mol Carcinog 45: 613-626
6. Chen R, Pan S, Brentnall TA, Aebersold R (2005) Proteomic profiling of pancreatic cancer for biomarker discovery. Mol Cell Proteomics 4: 523-533 (Pubitemid 40590569)
7. Crnogorac-Jurcevic T, Missiaglia E, Blaveri E, Gangeswaran R, Jones M, Terris B, Costello E, Neoptolemos JP, Lemoine NR (2003) Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent. J Pathol 201: 63-74 (Pubitemid 37121204)
8. Cross SS, Hamdy FC, Deloulme JC, Rehman I (2005) Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology 46: 256-269
9. de Graauw M, Tijdens I, Smeets MB, Hensbergen PJ, Deelder AM, van de Water B (2008) Annexin A2 phosphorylation mediates cell scattering and branching morphogenesis via cofilin activation. Mol Cell Biol 28: 1029-1040 (Pubitemid 351160059)
10. Dechat T, Pfleghaar K, Sengupta K, Shimi T, Shumaker DK, Solimando L, Goldman RD (2008) Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin. Genes Dev 22: 832-853
11. Deora AB, Kreitzer G, Jacovina AT, Hajjar KA (2004) An annexin 2 phosphorylation switch mediates p11-dependent translocation of annexin 2 to the cell surface. J Biol Chem 279: 43411-43418 (Pubitemid 39390640)
12. Donato R (2007) RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins. Curr Mol Med 7: 711-724
13. Esposito I, Penzel R, Chaib-Harrireche M, Barcena U, Bergmann F, Riedl S, Kayed H, Giese N, Kleeff J, Friess H, Schirmacher P (2006) Tenascin C and annexin II expression in the process of pancreatic carcinogenesis. J Pathol 208: 673-685
14. Farnaes L, Ditzel HJ (2003) Dissecting the cellular functions of annexin XI using recombinant human annexin XI-specific autoantibodies cloned by phage display. J Biol Chem 278: 33120-33126 (Pubitemid 37055758)
15. Gerke V, Creutz CE, Moss SE (2005) Annexins: linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 6: 449-461 (Pubitemid 40780557)
16. Ghaneh P, Costello E, Neoptolemos JP (2007) Biology and management of pancreatic cancer. Gut 56: 1134-1152
17. Golitsina NL, Kordowska J, Wang CL, Lehrer SS (1996) Ca2+-dependent binding of calcyclin to muscle tropomyosin. Biochem Biophys Res Commun 220: 360-365 (Pubitemid 126351722)
18. Gunning P, O'Neill G, Hardeman E (2008) Tropomyosin-based regulation of the actin cytoskeleton in time and space. Physiol Rev 88: 1-35
19. Hayes MJ, Shao D, Bailly M, Moss SE (2006) Regulation of actin dynamics by annexin 2. EMBO J 25: 1816-1826
20. Heizmann CW, Ackermann GE, Galichet A (2007) Pathologies involving the S100 proteins and RAGE. Subcell Biochem 45: 93-138
21. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics, 2008. CA Cancer J Clin 58: 71-96
22. Komatsu K, Kobune-Fujiwara Y, Andoh A, Ishiguro S, Hunai H, Suzuki N, Kameyama M, Murata K, Miyoshi J, Akedo H, Tatsuta M, Nakamura H (2000) Increased expression of S100A6 at the invading fronts of the primary lesion and liver metastasis in patients with colorectal adenocarcinoma. Br J Cancer 83: 769-774 (Pubitemid 30694486)
23. Logsdon CD, Simeone DM, Binkley C, Arumugam T, Greenson JK, Giordano TJ, Misek DE, Kuick R, Hanash S (2003) Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 63: 2649-2657 (Pubitemid 36605209)
24. Luu HH, Zhou L, Haydon RC, Deyrup AT, Montag AG, Huo D, Heck R, Heizmann CW, Peabody TD, Simon MA, He TC (2005) Increased expression of S100A6 is associated with decreased metastasis and inhibition of cell migration and anchorage independent growth in human osteosarcoma. Cancer Lett 229: 135-148 (Pubitemid 41262550)
25. Maelandsmo GM, Florenes VA, Mellingsaeter T, Hovig E, Kerbel RS, Fodstad O (1997) Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma. Int J Cancer 74: 464-469 (Pubitemid 27400171)
26. Mizutani A, Usuda N, Tokumitsu H, Minami H, Yasui K, Kobayashi R, Hidaka H (1992) CAP-50, a newly identified annexin, localizes in nuclei of cultured fibroblast 3Y1 cells. J Biol Chem 267: 13498-13504
27. Ohuchida K, Mizumoto K, Ishikawa N, Fujii K, Konomi H, Nagai E, Yamaguchi K, Tsuneyoshi M, Tanaka M (2005) The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target. Clin Cancer Res 11: 7785-7793 (Pubitemid 41611622)
28. Ohuchida K, Mizumoto K, Miyasaka Y, Yu J, Cui L, Yamaguchi H, Toma H, Takahata S, Sato N, Nagai E, Yamaguchi K, Tsuneyoshi M, Tanaka M (2007a) Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis. J Pathol 213: 275-282 (Pubitemid 350074017)
29. Ohuchida K, Mizumoto K, Ohhashi S, Yamaguchi H, Konomi H, Nagai E, Yamaguchi K, Tsuneyoshi M, Tanaka M (2006) S100A11, a putative tumor suppressor gene, is overexpressed in pancreatic carcinogenesis. Clin Cancer Res 12: 5417-5422 (Pubitemid 44497256)
30. Ohuchida K, Mizumoto K, Yu J, Yamaguchi H, Konomi H, Nagai E, Yamaguchi K, Tsuneyoshi M, Tanaka M (2007b) S100A6 is increased in a stepwise manner during pancreatic carcinogenesis: clinical value of expression analysis in 98 pancreatic juice samples. Cancer Epidemiol Biomarkers Prev 16: 649-654 (Pubitemid 46650564)
31. Oida Y, Yamazaki H, Tobita K, Mukai M, Ohtani Y, Miyazaki N, Abe Y, Imaizumi T, Makuuchi H, Ueyama Y, Nakamura M (2006) Increased S100A4 expression combined with decreased E-cadherin expression predicts a poor outcome of patients with pancreatic cancer. Oncol Rep 16: 457-463
32. Orre LM, Pernemalm M, Lengqvist J, Lewensohn R, Lehtio J (2007) Up-regulation, modification, and translocation of S100A6 induced by exposure to ionizing radiation revealed by proteomics profiling. Mol Cell Proteomics 6: 2122-2131
33. Ortiz-Zapater E, Peiro S, Roda O, Corominas JM, Aguilar S, Ampurdanes C, Real FX, Navarro P (2007) Tissue plasminogen activator induces pancreatic cancer cell proliferation by a non-catalytic mechanism that requires extracellular signal-regulated kinase 1/2 activation through epidermal growth factor receptor and annexin A2. Am J Pathol 170: 1573-1584 (Pubitemid 47339302)
34. Paciucci R, Tora M, Diaz VM, Real FX (1998) The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro. Oncogene 16: 625-633 (Pubitemid 28062342)
35. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108
36. Semov A, Moreno MJ, Onichtchenko A, Abulrob A, Ball M, Ekiel I, Pietrzynski G, Stanimirovic D, Alakhov V (2005) Metastasis-associated protein S100A4 induces angiogenesis through interaction with Annexin II and accelerated plasmin formation. J Biol Chem 280: 20833-20841 (Pubitemid 40776788)
37. Sharma MC, Sharma M (2007) The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target. Curr Pharm Des 13: 3568-3575 (Pubitemid 350238927)
38. Sheikh AA, Vimalachandran D, Thompson CC, Jenkins RE, Nedjadi T, Shekouh A, Campbell F, Dodson A, Prime W, Crnogorac-Jurcevic T, Lemoine NR, Costello E (2007) The expression of S100A8 in pancreatic cancer-associated monocytes is associated with the Smad4 status of pancreatic cancer cells. Proteomics 7: 1929-1940 (Pubitemid 46911010)
39. Shekouh A, Thompson C, Prime W, Campbell F, Hamlett J, Herrington C, Lemoine N, Crnogorac-Jurcevic T, Buechler M, Friess H, Neoptolemos J, Pennington S, Costello E (2003) Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma. Proteomics 3: 1988-2001 (Pubitemid 37305893)
40. Sitek B, Luttges J, Marcus K, Kloppel G, Schmiegel W, Meyer HE, Hahn SA, Stuhler K (2005) Application of fluorescence difference gel electrophoresis saturation labelling for the analysis of microdissected precursor lesions of pancreatic ductal adenocarcinoma. Proteomics 5: 2665-2679 (Pubitemid 40966494)
41. Suemizu H, Monnai M, Ohnishi Y, Ito M, Tamaoki N, Nakamura M (2007) Identification of a key molecular regulator of liver metastasis in human pancreatic carcinoma using a novel quantitative model of metastasis in NOD/SCID/gammacnull (NOG) mice. Int J Oncol 31: 741-751
42. Thompson CC, Ashcroft FJ, Patel S, Saraga G, Vimalachandran D, Prime W, Campbell F, Dodson A, Jenkins RE, Lemoine NR, Crnogorac-Jurcevic T, Yin HL, Costello E (2007) Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motility. Gut 56: 95-106 (Pubitemid 46044895)
43. Tomas A, Futter C, Moss SE (2004) Annexin 11 is required for midbody formation and completion of the terminal phase of cytokinesis. J Cell Biol 165: 813-822 (Pubitemid 38821972)
44. Tomas A, Moss SE (2003) Calcium- and cell cycle-dependent association of annexin 11 with the nuclear envelope. J Biol Chem 278: 20210-20216 (Pubitemid 36799218)
45. Varro A, Kenny S, Hemers E, McCaig C, Przemeck S, Wang TC, Bodger K, Pritchard DM (2007) Increased gastric expression of MMP-7 in hypergastrinemia and significance for epithelial-mesenchymal signaling. Am J Physiol Gastrointest Liver Physiol 292: G1133-G1140 (Pubitemid 46557781)
46. Vimalachandran D, Greenhalf W, Thompson C, Luttges J, Prime W, Campbell F, Dodson A, Watson R, Crnogorac-Jurcevic T, Lemoine N, Neoptolemos J, Costello E (2005) High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients. Cancer Res 65: 3218-3225 (Pubitemid 40524604)
47. Whiteman HJ, Weeks ME, Dowen SE, Barry S, Timms JF, Lemoine NR, Crnogorac-Jurcevic T (2007) The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D. Cancer Res 67: 8633-8642 (Pubitemid 47437439)
48. Yang YQ, Zhang LJ, Dong H, Jiang CL, Zhu ZG, Wu JX, Wu YL, Han JS, Xiao HS, Gao HJ, Zhang QH (2007) Upregulated expression of S100A6 in human gastric cancer. J Dig Dis 8: 186-193
49. Zeng FY, Gerke V, Gabius HJ (1993) Identification of annexin II, annexin VI and glyceraldehyde-3-phosphate dehydrogenase as calcyclin-binding proteins in bovine heart. Int J Biochem 25: 1019-1027 (Pubitemid 23186507)